LENZ Therapeutics, Inc. (LENZ) Operating Income (2022 - 2023)
LENZ Therapeutics (LENZ) has disclosed Operating Income for 2 consecutive years, with -$25.0 million as the latest value for Q4 2023.
- On a quarterly basis, Operating Income rose 6.59% to -$25.0 million in Q4 2023 year-over-year; TTM through Dec 2023 was -$77.6 million, a 26.55% increase, with the full-year FY2024 number at -$58.6 million, up 19.08% from a year prior.
- Operating Income was -$25.0 million for Q4 2023 at LENZ Therapeutics, roughly flat from -$25.0 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$12.6 million in Q1 2023 to a low of -$26.8 million in Q2 2022.